Company intelligence / Profile preview

Agena Bioscience

San Diego, California, United Statesagenabio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Agena Bioscience develops and commercializes the MassARRAY System—a MALDI‑TOF mass spectrometry-based genetic analysis instrument—used globally for high-throughput targeted genotyping and molecular diagnostics. Their technology enables multiplexed detection of clinically relevant variants in oncology, inherited diseases, pharmacogenomics, and infectious disease testing. The company’s products have received FDA Emergency Use Authorization for COVID‑19 testing and CE-IVD approval in Europe. Their diagnostic panels can detect dozens to over a hundred variants from a single sample with high sensitivity.

Therapeutic areas: OncologyMetabolic DisordersRare DiseasesInfectious Diseases
Modalities: DeviceDiagnostic panelMolecular diagnostics technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Agena Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agena Bioscience.

Explore the full profile